Research in Social & Administrative Pharmacy最新文献

{"title":"Effectiveness of pharmacist-led antimicrobial stewardship programs in perioperative settings: A systematic review and meta-analysis","authors":"Lina Naseralallah,&nbsp;Somaya Koraysh,&nbsp;Bodoor Aboujabal,&nbsp;May Alasmar","doi":"10.1016/j.sapharm.2024.08.006","DOIUrl":"10.1016/j.sapharm.2024.08.006","url":null,"abstract":"<div><h3>Objective</h3><p>We sought to characterize and evaluate the effectiveness of pharmacist-led AMS interventions in improving antimicrobial use and subsequent surgical site infections (SSI) in perioperative settings.</p></div><div><h3>Methods</h3><p>A systematic review and meta-analysis was conducted by searching PubMed, Embase and CINAHL. Two independent reviewers extracted the data using the Descriptive Elements of Pharmacist Intervention Characterization Tool and undertook quality assessment using the Crowe Critical Appraisal. A meta-analysis was conducted using a random-effect model.</p></div><div><h3>Results</h3><p>Eleven studies were included in this review. Pharmacists were found to have various roles in AMS, including educational sessions, ward rounds, audits and feedback, and guidelines development. The discussion of interventions lacked details on the development. A meta-analysis revealed that pharmacist-led AMS programs in perioperative settings was associated with a significant improvement in antibiotic selection (OR 4.29; 95 % CI 2.52–7.30), administration time (OR 4.93; 95 % CI 2.05–11.84), duration (OR 5.27; 95 % CI 1.58–17.55), and SSI (OR 0.51; 95 % CI 0.34–0.77).</p></div><div><h3>Conclusion</h3><p>Pharmacist-led AMS programs were effective in improving antimicrobial prescribing while reducing SSI; however most studies were of moderate quality. Studies lacked the utilization of theory to develop interventions, therefore, it is not clear whether theory-derived interventions are more effective than those without a theoretical element. High-quality, multicomponent, theory-derived, interventional studies using appropriate methodology and standardized data collection, are needed.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 11","pages":"Pages 1023-1037"},"PeriodicalIF":3.7,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124002377/pdfft?md5=b212c49453f6890ab4dfe0a2d5294657&pid=1-s2.0-S1551741124002377-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141996650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Health outcomes following provision of Home Medicines Reviews for older people receiving aged care services at home","authors":"Janet K. Sluggett ,&nbsp;Gillian E. Caughey ,&nbsp;Tracy Air ,&nbsp;Catherine Lang ,&nbsp;Max Moldovan ,&nbsp;Grant Martin ,&nbsp;Andrew C. Stafford ,&nbsp;Stephen R. Carter ,&nbsp;Shane Jackson ,&nbsp;Steve L. Wesselingh ,&nbsp;Maria C. Inacio","doi":"10.1016/j.sapharm.2024.08.004","DOIUrl":"10.1016/j.sapharm.2024.08.004","url":null,"abstract":"<div><h3>Background</h3><p>The impact of Home Medicines Reviews (HMRs) on long-term health outcomes among individuals receiving long-term in-home aged care services is unknown.</p></div><div><h3>Objectives</h3><p>To examine associations between HMR provision and hospitalization, long-term care facility (LTCF) entry and mortality among older people receiving long-term in-home aged care services.</p></div><div><h3>Methods</h3><p>This retrospective cohort study included individuals aged 65–105 years from three Australian states who accessed in-home aged care services between 2013 and 2017. Using propensity score matching, HMR recipients (n = 1530) were matched to individuals who did not receive an HMR (n = 1530). Associations between HMR provision and outcomes were estimated using multivariable regression models.</p></div><div><h3>Results</h3><p>Over a median of 414 days (interquartile range 217–650) of follow-up, HMR provision was not associated with hospitalizations for unplanned events (subdistribution hazard ratio (sHR) 1.04, 95%CI 0.96–1.14), falls-related hospitalizations (sHR 0.97, 95%CI 0.83–1.13), LTCF entry (sHR 0.97, 95%CI 0.83–1.13), or all-cause mortality (adjusted HR 0.86, 95%CI 0.72–1.01).</p></div><div><h3>Conclusions</h3><p>In a cohort of older people receiving long-term in-home aged care services, no differences in unplanned hospitalizations, falls, LTCF entry or mortality were observed those with HMRs compared to those that did not receive an HMR.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 11","pages":"Pages 1064-1069"},"PeriodicalIF":3.7,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124002353/pdfft?md5=a4ee005f2dccba6a7693a2642cc9d201&pid=1-s2.0-S1551741124002353-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of pharmacist-led pharmaceutical care on health-related and pharmaceutical therapy-related quality of life in patients with heart failure: A randomized controlled trial","authors":"Phantipa Sakthong ,&nbsp;Warangkana Boonyanuwat","doi":"10.1016/j.sapharm.2024.08.003","DOIUrl":"10.1016/j.sapharm.2024.08.003","url":null,"abstract":"<div><h3>Background</h3><p>Data on the impact of pharmacist-led pharmaceutical care (PC) on pharmaceutical therapy-related and health-related quality of life (HRQoL) and their sensitivities to PC provision in patients with heart failure (HF) are scarce.</p></div><div><h3>Objectives</h3><p>This study aimed to assess the impact of pharmacist-led PC on HRQoL employing the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and 5-level EuroQol 5 dimension (EQ-5D-5L) and on pharmaceutical therapy-related quality of life using the Patient-Reported Outcomes Measure of Pharmaceutical Therapy (PROMPT) in HF patients and compare sensitivities to the PC provision of these three tools.</p></div><div><h3>Methods</h3><p>A single-blinded randomized controlled trial was conducted at a tertiary public hospital in Thailand between November 2022 and May 2023. Overall, 250 patients were randomly divided into the usual care (UC) (N = 124) and PC (N = 126) groups. Mixed effects models were used to investigate the differences in the mean change scores of PROMPT, EQ-5D-5L, and MLHFQ between the UC and PC groups. The sensitivities to PC provision of the three measures were evaluated using standardized effect sizes (SESs).</p></div><div><h3>Results</h3><p>Significant differences were found in five of eight domains and the total score of the PROMPT between the PC and UC groups (all <em>p</em> &lt; 0.05). However, no significant differences were found in the EQ-5D-5L and MLHFQ between the two groups (both <em>p</em> &gt; 0.05). The SESs of the five domains and total score of PROMPT ranged from 0.29 to 1.65, considered small-to-large effect sizes, whereas the SESs of EQ-5D-5L and MLHFQ were −0.4 to 0, considered small effect sizes.</p></div><div><h3>Conclusions</h3><p>Pharmacist-led PC can positively affect pharmaceutical therapy-related quality of life using PROMPT in HF patients. Additionally, PROMPT is more sensitive to PC provision than EQ-5D-5L and MLHFQ.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 11","pages":"Pages 1058-1063"},"PeriodicalIF":3.7,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141996651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is it time to stop counting on saturation in pharmacy research? Ideas for a new way forward","authors":"Matthew Witry ,&nbsp;Lisa Guirguis","doi":"10.1016/j.sapharm.2024.08.002","DOIUrl":"10.1016/j.sapharm.2024.08.002","url":null,"abstract":"<div><p>The concept of saturation is commonly mentioned in pharmacy research, but there has been recent debate among the applied qualitative research community that challenges the appropriateness of this construct for many qualitative research efforts. This begins by describing the origins of saturation as a grounded theory construct and discusses how saturation is currently being used. Three challenges are discussed related to the use of saturation in pharmacy related to the epistemological, methodological, and practical use of saturation by pharmacy researchers and how they relate to the goals and reporting quality of pharmacy practice research The commentary describes how the concept of information power and established guidance on analysis quality can better justify sample size inform decisions about when to cease further data collection, hopefully increasing the transparency of reporting and supporting rigorous and coherent analyses.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 11","pages":"Pages 1070-1074"},"PeriodicalIF":3.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study","authors":"Pooria Zare ,&nbsp;Hossein Poustchi ,&nbsp;Zahra Mohammadi ,&nbsp;Bita Mesgarpour ,&nbsp;Mohammadreza Akbari ,&nbsp;Alireza Kamalipour ,&nbsp;Seyed Reza Abdipour-Mehrian ,&nbsp;Elham-Sadat Hashemi ,&nbsp;Arash Ghamar-Shooshtari ,&nbsp;Seyed Ali Hosseini ,&nbsp;Reza Malekzadeh ,&nbsp;Hamed Bazrafshan Drissi ,&nbsp;Fatemeh Malekzadeh ,&nbsp;Hossein Molavi Vardanjani","doi":"10.1016/j.sapharm.2024.07.006","DOIUrl":"10.1016/j.sapharm.2024.07.006","url":null,"abstract":"<div><p>Polypharmacy, defined here as the concomitant use of five or more medications, is a significant health issue, particularly affecting individuals with chronic diseases like hypertension (HTN). To compare individuals with and without HTN in term of polypharmacy, and to investigate correlates of polypharmacy and medication use patterns in individuals with HTN in southwest Iran. This cross-sectional study used the baseline data of 9270 participants of the Pars Cohort Study (PCS) with a mean age of 52.6 ± 9.7 years. Poisson multivariable modeling was applied to identify correlates of polypharmacy, and Lexicomp® was used to assess drug-drug interactions. Anatomical Therapeutic Chemical classification was used to describe the pattern of medication use. The prevalence of polypharmacy in individuals without hypertension was 4.7 % (4.2%–5.2 %) vs. 23.7 % (22.1%–25.3 %) in individuals with hypertension (P &lt; 0.001). Individuals with hypertension from middle-high socioeconomic status (SES) had a 1.51-fold higher prevalence of polypharmacy than vs. low SES. Those with more than three comorbidities had a 5.18 times higher prevalence of polypharmacy than those with isolated hypertension. Calcium channel blockers were the most common antihypertensives (20.9 %). In terms of drug-drug interactions, type C interactions were most prevalent among participants with hypertension and polypharmacy (76.0 %). Our findings imply a fairly high prevalence of polypharmacy and drug-drug interactions among individuals with hypertension; to tackle this issue, we recommend a national pharmacovigilance system, training programs for primary care physicians, public education and awareness campaigns, drug-checking campaigns, targeted screenings to alter modifiable risk factors, and the use of safe combination pills.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 11","pages":"Pages 1038-1046"},"PeriodicalIF":3.7,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141890512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Best practice in dementia health care: Key clinical practice pointers from a national conference and innovative opportunities for pharmacy practice","authors":"Sam Keast ,&nbsp;James R. Broatch ,&nbsp;Stephen Chung ,&nbsp;Renee Dixon ,&nbsp;Roshna Dongol ,&nbsp;Leanne Emerson ,&nbsp;Alan Hayes ,&nbsp;Sandra Iuliano ,&nbsp;Itamar Levinger ,&nbsp;Xiaoping Lin ,&nbsp;Erin McKnight ,&nbsp;Kirsten Moore ,&nbsp;Hanatsu Nagano ,&nbsp;Alexandra G. Parker ,&nbsp;Catherine M. Said ,&nbsp;Myrla Sales ,&nbsp;Rees Thomas ,&nbsp;Clare White ,&nbsp;Jesse Zanker ,&nbsp;Julia Gilmartin-Thomas","doi":"10.1016/j.sapharm.2024.07.005","DOIUrl":"10.1016/j.sapharm.2024.07.005","url":null,"abstract":"<div><h3>Objective</h3><p>Sub-optimal care of people living with dementia has serious consequences for older populations. The 2021 Australian Royal Commission noted that a large proportion of older adults in aged care live with dementia, yet there are limitations in the knowledge and understanding of staff who care for them. In the pursuit of educating pharmacists, physicians, allied health care professionals, researchers, academics, people living with dementia and their carers, and the public, who are facing the challenges of dementia management, the ‘Best Practice in Dementia Health Care’ conference was held on November 10, 2022 at Western Health (Sunshine Hospital, Melbourne, Australia).</p></div><div><h3>Methods</h3><p>Sixteen experts presented on the current practice and challenges associated with delivering best practice dementia health care to older Australians, often highlighting how medication-related challenges impacted on their area of practice.</p></div><div><h3>Results</h3><p>Presenters highlighted the importance of individualised medication management plans, considerations of culture and Indigenous communities, the role of technology, and the impact of exercise and the physical environment on care of people living with dementia. Key clinical practice messages from each expert presenter fit into four main topics: ‘navigating complexities of medication management’; ‘enhancing wellbeing’; ‘supportive settings and environments’; and ‘programs and services improving care’.</p></div><div><h3>Conclusions</h3><p>Pharmacists are crucial members of allied health care teams. They have the necessary medication and comorbidity expertise to review medication regimens, liaise with all health care providers, and provide holistic, pharmacological and non-pharmacological patient education. Towards providing best practice dementia health care, pharmacists can contribute in several ways, such as providing health practitioner education to increase understanding about medications and how they can impact on allied health practice, to ensure that medications are prescribed appropriately and safely. Further, pharmacists can make available resources to ensure people living with dementia receive culturally safe and appropriate care, while advocating for greater understanding of the history and experiences of people living with dementia to ensure care aligns with their day-to-day routines. Finally, pharmacists can provide peer-support to other health care professionals and care staff to ensure optimal management of behavioural and psychological symptoms of dementia. The information and insights shared at the conference can serve as a valuable resource for pharmacists and other health care professionals and researchers working to improve the lives of those living with dementia.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 10","pages":"Pages 1014-1021"},"PeriodicalIF":3.7,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying the key determinants of a community pharmacy based bladder and bowel service","authors":"Alan Uren ,&nbsp;Margaret Watson ,&nbsp;Shoba Dawson ,&nbsp;Ade Williams ,&nbsp;Hugh McLeod ,&nbsp;David Chandler,&nbsp;Alice Berry ,&nbsp;Nikki Cotterill","doi":"10.1016/j.sapharm.2024.07.003","DOIUrl":"10.1016/j.sapharm.2024.07.003","url":null,"abstract":"<div><h3>Objectives</h3><p>Community pharmacies and their personnel present an opportunity to implement new services for bladder and bowel continence care. Underpinned by the COM-B model of capability (C), opportunity (O), motivation (M), Behaviour (B)), this study explored the opinions of healthcare staff and users of community pharmacy services, to inform the development of a new pharmacy bladder and bowel service (PBBS).</p></div><div><h3>Methods</h3><p>A qualitative design was adopted by conducting in-depth semi-structured interviews with pharmacy staff, users of community pharmacy services, bladder and bowel service staff, and professionals involved with commissioning services. A thematic analysis was used, and resulting themes were mapped onto the components of the COM-B model.</p></div><div><h3>Results</h3><p>A total of 27 participants were interviewed that represented the four groups of participants. A pro-active, protocolised PBBS was envisaged, involving targeted advice and provision of self-help materials, medication support, and referral/follow-up assessment as appropriate. Training programs for pharmacy staff, adequate funding/remuneration and information technology, awareness campaigns, policy support and guidance were identified as key behavioural targets for the success of a potential PBBS. Workforce time and capacity, service user embarrassment and stigma were potential barriers.</p></div><div><h3>Conclusions</h3><p>The study identified a range of elements to be considered in the design and implementation of a successful PBBS. Informed by the evidence presented by this study, a multi-faceted approach to co-design the service will be required to ensure it is fit for purpose for all healthcare public and policy stakeholders.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 10","pages":"Pages 1006-1013"},"PeriodicalIF":3.7,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124002067/pdfft?md5=445cb053b56e84bbcd3ef6a0c7b51da7&pid=1-s2.0-S1551741124002067-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141853534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and validation of the mobile adherence satisfaction scale (MASS) for medication adherence apps","authors":"Rajat Rana ,&nbsp;Baharudin Bin Ibrahim ,&nbsp;Hasniza Binti Zaman Huri ,&nbsp;Izyan Binti A. Wahab ,&nbsp;Kayatri Govindaraju ,&nbsp;Mohd Syamir Mohamad Shukeri ,&nbsp;Chow Kyn Ng ,&nbsp;Siew Chin Ong","doi":"10.1016/j.sapharm.2024.07.004","DOIUrl":"10.1016/j.sapharm.2024.07.004","url":null,"abstract":"<div><h3>Objective</h3><p>To develop and validate the Mobile Adherence Satisfaction Scale (MASS) for assessing user satisfaction with mobile health applications aimed to improve medication adherence.</p></div><div><h3>Methods</h3><p>The study involved patients over 18 with asthma, hypertension, heart failure, or diabetes, who used the CareAide® app for six months. Scale development included a literature review, expert consultations, and patient interviews, initially identifying 129 items. These were refined to 27 using a two-round Delphi technique and grouped into six dimensions: user interface, perceived usability, system quality, service quality, feature satisfaction, and general satisfaction. A pilot study with 30 participants further refined the model, which was then validated with 135 participants using exploratory and confirmatory factor analyses in SPSS 29 and SmartPLS 4. Data were collected via self-administered questionnaires.</p></div><div><h3>Results</h3><p>A total of 135 complete questionnaires were analysed. Respondents had an average age of 66.7 years (SD = 11.6) with 42.2 % male (n = 57) and 57.8 % female (n = 78). After removal of an item due to cross loading, exploratory factor analysis resulted six dimensions and 26 items with Kaiser-Meyer-Olkin measure of 0.837 and Bartlett's Test of Sphericity (χ²(n = 325) = 2085.673, <em>P</em> &lt; 0.001). The confirmatory factor analysis confirmed high reliability and validity: Cronbach's alpha values &gt; 0.70 for each dimension and an overall alpha of 0.89, with Composite Reliability and Average Variance Extracted both &gt;0.70 and &gt;0.50, respectively, for each dimension. Structural model indicated a significant positive impact of user interface (β = 0.226, <em>P</em> = 0.006) and feature satisfaction (β = 0.230, <em>P</em> = 0.002) on general satisfaction, explaining 23.1 % of the variance (R² = 0.231).</p></div><div><h3>Conclusion</h3><p>The study developed and validated the MASS, a reliable tool for assessing user satisfaction with mHealth apps. User interface design and feature satisfaction are key for long-term engagement and consistent medication adherence.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 10","pages":"Pages 959-968"},"PeriodicalIF":3.7,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141845456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A mixed-methods cross-sectional study to evaluate the public acceptability of a novel pharmacy-based response service for domestic abuse and/or suicidal ideation","authors":"Josie Solomon ,&nbsp;Hayley Gorton ,&nbsp;Ana Maria Barcelos ,&nbsp;Tracey Latham-Green ,&nbsp;Samantha Williams ,&nbsp;Elise Rowan ,&nbsp;Peter Knapp ,&nbsp;Claire Henderson ,&nbsp;Mark Gussy ,&nbsp;Rebecca Barnes","doi":"10.1016/j.sapharm.2024.07.002","DOIUrl":"10.1016/j.sapharm.2024.07.002","url":null,"abstract":"<div><h3>Background</h3><p>Domestic abuse (DA) and suicidal ideation (SI) are prevalent and often co-occur. Numerous practical and psychosocial barriers inhibit help-seeking, including accessibility and confidentiality concerns. Early intervention and referral are essential for both DA and SI. Pharmacies are accessible and may be perceived as a discreet venue for a DA and SI response service. There is a growing body of literature about the role of community pharmacy teams in suicide prevention and assisting domestic abuse victims globally. Whilst there have been some interventions in UK pharmacies to support domestic abuse victims and encouragement of staff training in suicide prevention, there is currently no commissioned service for DA and/or SI in pharmacies in the UK.</p></div><div><h3>Objective</h3><p>To assess public acceptability of a novel response service in community pharmacy for people in danger from domestic abuse and/or suicidal ideation.</p></div><div><h3>Methods</h3><p>Data collection consisted of an online public survey running for 6 weeks and qualitative interviews with pharmacy customers. Descriptive statistics were used to present the survey results and interviews were audio recorded, transcribed verbatim and then analysed using the Framework Analysis method and NVivo 11.</p></div><div><h3>Results</h3><p>The majority of 501 survey respondents and all 12 customer interview participants were supportive of offering a response service for DA and/or SI in community pharmacy. Participants emphasised the need for appropriate staff training and support. They considered it an ethical and accessible approach and the majority said that they would recommend such a service to family or friends, and use it themselves if needed. However, awareness of the service was low and marketing materials were considered insufficiently clear.</p></div><div><h3>Conclusions</h3><p>There is strong public support and acceptability for a response service covering both suicidal ideation and domestic abuse in community pharmacies. Further research is required to develop appropriate marketing materials.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 10","pages":"Pages 969-977"},"PeriodicalIF":3.7,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124002055/pdfft?md5=56bcfa94df344c077b27a2b04361247b&pid=1-s2.0-S1551741124002055-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141853366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee","authors":"","doi":"10.1016/j.sapharm.2024.07.001","DOIUrl":"10.1016/j.sapharm.2024.07.001","url":null,"abstract":"<div><h3>Background</h3><p><span>Increasing access to naloxone reduces opioid-related morbidity and mortality. Primary care and </span>community pharmacy settings are critical access points, yet limited theoretical research has examined naloxone prescribing and dispensing behaviors.</p></div><div><h3>Objectives</h3><p>To determine if the theory of planned behavior (TPB) combined with theoretical constructs from communication science explains intentions to co-prescribe and discuss co-dispensing naloxone among primary care physicians and community pharmacists, respectively.</p></div><div><h3>Methods</h3><p>This cross-sectional study surveyed cohorts of licensed primary care physicians and community pharmacists in Tennessee in 2017. Intentions were measured using profession-specific case vignettes, whereby they were asked given 10 similar patients, how many times (0–10) would they co-prescribe or discuss co-dispensing naloxone. Bivariate and multivariable analyses were used.</p></div><div><h3>Results</h3><p>The analytic sample included 295 physicians (response rate = 15.6 %) and 423 pharmacists (response rate = 19.4 %). Approximately 65 % of physicians reported never intending to co-prescribe naloxone (0 out of 10 patients), while 47 % of pharmacists reported never intending to discuss co-dispensing. All TPB constructs—attitudes (AOR = 1.32, CI = 1.16–1.50), subjective norms (AOR = 1.17, CI = 1.06–1.30), and perceived behavioral control (AOR 1.16, CI = 1.02–1.33)—were associated with an increased likelihood of pharmacists always (versus never) discussing co-dispensing. Similarly, two TPB constructs—attitudes (AOR = 1.41, CI = 1.19–1.68) and subjective norms (AOR = 1.22, CI = 1.08–1.39)—were associated with an increased likelihood of physicians always co-prescribing. Among physicians only, one communication construct—self-perceived communication competence (AOR = 1.19, CI = 1.01–1.41)—was associated with an increased likelihood of always co-prescribing.</p></div><div><h3>Conclusion</h3><p>Findings support the value of theory, particularly TPB, in explaining primary care physician intentions to co-prescribe and community pharmacist intentions to discuss co-dispensing naloxone.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 10","pages":"Pages 978-985"},"PeriodicalIF":3.7,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}